Financials

  • Market Capitalization 329.3 M
  • Employee 35
  • Founded 2008
  • CEO N/A
  • Website www.inhibikase.com
  • Headquarter Delaware, United States
  • FIGI BBG005TP2339
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.61
Rapporto prezzo/fatturato
54.94

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3212
STRO
Sutro Biopharma, Inc. - Common Stock
19.68 USD-3.77%-3.24%-17.90%+13.17%326.32 M USD
3227
ABEO
Abeona Therapeutics Inc. - Common Stock
5.85 USD-1.18%-3.31%-9.30%-14.47%334.53 M USD
3257
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.39 USD+1.89%+1.51%+5.69%-2.53%325.89 M USD
3276
IMRX
Immuneering Corporation - Class A Common Stock
4.91 USD-1.60%-5.76%+18.31%-12.94%317.66 M USD

Notizie